Long-term Follow-Up of a Phase 2 Study of All-Trans Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin in Acute Promyelocytic Leukemia.
CANCER（2025）
关键词
acute promyelocytic leukemia (APL),arsenic trioxide (ATO),all-trans retinoic acid (ATRA),clinical trial,gemtuzumab ozogamicin (GO)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要